Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

January 16, 2022
Preprint
Open Access

Integrative in situ mapping of single-cell transcriptional states and tissue histopathology in an Alzheimer's disease model

BioRxiv : the Preprint Server for Biology
H. ZengXiao Wang
January 16, 2022

The modulation of neuroinflammation by inducible nitric oxide synthase.

Journal of Cell Communication and Signaling
Alberto Fernando Oliveira Justo, Claudia Kimie Suemoto
January 16, 2022
Review

A review of dementia, focusing on the distinct roles of viral protein corona and MMP9 in dementia: Potential pharmacotherapeutic priorities.

Ageing Research Reviews
Siva Prasad Panda, Urvashi Soni
January 15, 2022

Plasma Lipocalin 2 in Alzheimer's disease: potential utility in the differential diagnosis and relationship with other biomarkers.

Alzheimer's Research & Therapy
Peter HermannFranc Llorens
January 15, 2022

Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer's disease mice.

Proceedings of the National Academy of Sciences of the United States of America
Min Hee ParkJae-Sung Bae
January 15, 2022

Capillary Stalling: A Mechanism of Decreased Cerebral Blood Flow in AD/ADRD.

Journal of Experimental Neurology
Reece CrumplerFan Fan
January 14, 2022
Preprint
Open Access

Using intracerebral microdialysis to probe the efficacy of repurposed drugs in Alzheimer's disease pathology

BioRxiv : the Preprint Server for Biology
Christiana BjorkliI. Sandvig
January 14, 2022
Preprint
Open Access

Helicobacter Pylori Urease: Potential Contributions to Alzheimer’s Disease

Preprints.org
Augusto F. UbertiCelia Regina Carlini
January 14, 2022

Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.

Brain : a Journal of Neurology
Claire BridelSebastiaan Engelborghs
January 13, 2022
Preprint
Open Access

Patients with Alzheimer's disease have increased cellular amyloid uptake

MedRxiv : the Preprint Server for Health Sciences
Dmitry V ZaretskyY. I. Molkov
January 14, 2022

Braiding Braak and Braak: Staging patterns and model selection in network neurodegeneration.

Network Neuroscience
Prama PutraAlain Goriely
January 14, 2022

Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Jennifer A FronteraThomas Wisniewski
January 14, 2022

Photo-Oxygenation: An Innovative New Therapeutic Approach Against Amyloidoses.

Advances in Experimental Medicine and Biology
Tetsuo IkedaTaisuke Tomita
January 13, 2022
Preprint
Open Access

Bulk and Single-nucleus Transcriptomics Highlight Intra-telencephalic and Somatostatin Neurons in Alzheimer's Disease

BioRxiv : the Preprint Server for Biology
M. E. ConsensD. Felsky
January 13, 2022
Review

Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease.

Neural Regeneration Research
Alejandro R RodaSandra Villegas

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-abeta/04a02fd8-ebb8-4fd7-a5af-a23ea43ba447